Alteration of WWOX in human cancer: a clinical view
- PMID: 25681467
- PMCID: PMC4935223
- DOI: 10.1177/1535370214561953
Alteration of WWOX in human cancer: a clinical view
Abstract
WWOX gene is located in FRA16D, the highly affected chromosomal fragile site. Its tumor suppressor activity has been proposed on a basis of numerous genomic alterations reported in chromosome 16q23.3-24.1 locus. WWOX is affected in many cancers, showing as high as 80% loss of heterozygosity in breast tumors. Unlike most tumor suppressors impairing of both alleles of WWOX is very rare. Despite cellular and animal models information on a WWOX role in cancer tissue is limited and sometimes confusing. This review summarizes information on WWOX in human tumors.
Keywords: WWOX; cancer; tumor suppressor gene.
© 2015 by the Society for Experimental Biology and Medicine.
References
-
- Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle Georget Tex 2007; 6: 1006–10. - PubMed
-
- Spandidos DA. Oncogenes and tumor suppressor genes as paradigms in oncogenesis. J BUON 2007; 12: S9–12. - PubMed
-
- Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4: 665–76. - PubMed
-
- Plaza-Menacho I, Mologni L, McDonald NQ. Mechanisms of RET signaling in cancer: current and future implications for targeted therapy. Cell Signal 2014; 26: 1743–52. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
